With the highly-valued support from your business partner, Tram Trinh (CEO VITAnLINK, A Health Tech Accelerator in Paris), we have the chance to look over the Swiss start-up border and follow some international companies who are engaged in the area of healthcare and the opportunities the blockchain technology can offer in this field, as a benefit for people and patients.

I’m proud that we can provide our HEALTHINAR followers with a glimpse of the exciting times and dynamic team spirit of Iryo, a very promising start-up. With a patient-driven approach, they are developing an open-sourced EHR platform, that gives patients, hospitals, and medical research institutions complete control over their healthcare data. Their goal is to create a global and participatory healthcare ecosystem, based on the values of data security, maximum interoperability, and privacy.

Enjoy this week’s read, an interview with Vasja Bočko, (CEO Iryo) and Tjaša Zajc (Business developer and Communications Manager, Iryo).

Iryo_Vasja Bočko_blogpost_HEALTHINARIryo_Tjasa Zajc_blogpost_HEALTHINAR

“We take best practices learned in developed countries and bring it to the developing ones” – or: How Iryo is creating a global participatory healthcare ecosystem

Being from the world of IT, what urged you to tackle the highly regulated healthcare sector coming from the advanced IT world?

Tjaša: Compared to other industries, IT in healthcare is years behind in offering healthcare providers and patients a good user experience. Most IT providers provide vendor lock-in systems, making the exchange of data and interoperability extremely difficult. We are creating a system that is built on a standard that can increase interoperability (openEHR). Moreover, Iryo will be open-sourced, making sure there that vendor lock-in is non-existent. Blockchain adds a layer of transparency and immutability that will make the system more secure and trustworthy.

And so, why do you believe that Iryo will be able to outperform the big players in this space?

Vasja: I would say they all are facing the innovator’s dilemma, in reference to the book of The Innovator’s Dilemma: When New Technologies Cause Great Firms to Fail by Clayton M. Christensen. Because these traditional players have always been successful in existing models, they can’t get out of this legacy mode easily and quickly.

The markets we believe we can have the fastest impact on are developing markets such as Africa and/or parts of the Middle East, where the markets and regulations are less developed, leaving space for new players.

How does Iryo turn this vision into reality?

Tjaša: We are currently working with a non-profit organization called, Walk with me, that is active in refugee camps in the Middle East. It was introduced to us by one of our advisors, Brian de Francesca. Facing a severe lack of resources, most needs are tended to before an EMR system in a refugee camp. On the other hand, patients with chronic conditions tend to spend many years in these camps. Offering a system, in which they will be able to have their medical data stored on their smartphones is a step forward to improving their continued care. When they leave a refugee camp, they will be able to take all their medical data with them. Blockchain technology will be the primary solution enabling them to become the decision makers around their data. They will be able to grant or revoke access to their medical records based on their needs.

Vasja: Refugees have minimal resources, but one thing that holds a significant amount of to them is their smartphones and having internet access. The turn over of healthcare professionals in refugee camps is high, as they come through various NGOs. We are building an IT system that will be user-friendly for healthcare professionals and patients alike, consequently helping with the accuracy of medical records.

Given the number of refugees, and the capacity of smartphones, how can they store all this data?

Vasja: Big files such as imagining diagnostics results, will not be stored on the phone directly. Iryo provides a cloud-based platform that can store the additional data from the patients free of charge. The refugee project is our pilot project to prove the concept and eventually design a model for scaling to other places with similar challenges regarding connectivity and infrastructure.

What are your target segments and business model?

Vasja: Our software will be available as a SaaS freemium service. If a healthcare provider has IT capabilities for maintenance, they can use it as such or pay us to service them. Additional revenue streams will be local customization, tailor-made solutions. The most prominent potential we see is for Iryo to become the global platform for researchers who would have to pay for the access to patient records by incentivizing patients to open their medical files in exchange for Iryo tokens.

What is your unique message that you would like to send to entrepreneurs, investors, healthcare providers, researchers, here and today?

Tjaša: We will need to ramp up our development team in the near future in order to further develop a robust and reliable product.

Iryo_team_blogpost_HEALTHINAR

The core Iryo team with some of the advisors

What tenacity and long-term commitment! What drives you guys?

Vasja: We have all worked in IT which generally benefits from quick progress. A few of us initially worked in healthcare which is where we observed the inefficiencies concerning IT infrastructure across the board. The gap is massive, and unacceptable in this day and age. We want to bring the best practices and approach in IT to the healthcare world.

Tjaša: My personal interest in healthcare derives from being a chronic patient for more than 15 years now. As a former healthcare journalist, I follow closely where healthcare system inefficiencies are and what solutions could address them. We want to be the catalyst for change.

So this is what makes you wake up every day?

Tjaša: Yes, striving to create a meaningful social impact.

Kind of a Robin the Hood in healthcare?

Tjaša: I wouldn’t quite say Robin Hood as that would mean we would have to steal from the rich to give to the poor, but yes we attempt to take best practices learned in developed countries and bring them to the developing ones.

Learn more about Iryo and their projects:

By Tram Trinh

Bayer announced a new global head for digital health and finished its 3rd accelerator batch. Merck has officially doubled the size of its venture unit and is launching its 3rd accelerator batch in 2017. Many ‘big pharma’companies including Roche, Pfizer and Takeda have started to reach out to the startup world, attending most of the key European digital health events (Health 2.0, ECHAlliance, FT healthcare, Frontiers Health etc.). Not surprisingly, these initiatives created a flow of digital health entrepreneurs rushing towards partnerships with the big pharma companies in hope to engage with a potential exit candidate.

Startup-image-800x638

Pilot-isis – a typical infection of the pharma companies

Nevertheless the path to exit with a big pharma can be a daunting journey that can last a minimum of 2-3 years. Like any big corporations, they are huge organizations. Disseminating new digital health products across a base of a minimum of 100,000 employees (scattered around the globe) is a serious long-term effort that requires a lot of attention and time.

One of the major pitfalls a startup can fall into are pilots that end up getting stuck in one country/division/function and never scale globally. For example, if startups knock at the marketing door, chances are that their job priority in an affiliate or region is to launch a drug and deliver targeted numbers. Their focus is miles away from scaling up a newly experimented digital health innovation, often perceived merely as an add-on to their drug-selling business model (unless it’s an app that can be used immediately as a marketing channel to support drug branding).

“There is some unavoidable investment time”, says Fredrik Debong, co-founder of mySugr, a startup focused around diabetes. “It is important to define and agree on the KPIs with your C-level pharma contacts right from the start and maintain an up-to-date discussions you will most likely shorten the timeline.” If you start the relationship with no incentives for the pharma management to drive a project with vague uncertain envisioned results, you can be guaranteed your pilot remains a pilot for a long time.”

One success of mySugr with Novo Nordisk relies on the clarity of the promise from the start: educating the market fast based on a trusted loyal base of patients. MySugr B2C model represents a recurring loyal user base of close to 1 million patients. And recent news proved it right: Swiss Pharma € 50 bn Roche acquired MySugr in June 2017 at an estimated € 70-80  Million sale prices to advance with MySugr Roche’s own digital strategy on the diabetes market.

Medtech – alternative gate way to the health care system?

However, with medtech it appears that pilots are not needed and the timeframe between the date of initial discussions to rolling out the digital health solution can go down to 6 months, as demonstrated by mySugr in partnering with Roche. Traditional medtechs are currently in transition: they must adapt to several metrics shifts in reimbursement regulation, consumer empowerment, digital enablement and their competitive landscape. As a result they are opening up faster to increasing partnerships with the digital health startup ecosystem. Here are the 7 driving factors:

1)   New European MDR Medical Device Regulation

The 5th April 2017 EU Medical Devices Regulation requires more information transparency to consumers, vigilance and market surveillance, safety and reliability in medical devices. This is leading to portfolio rationalization at medtechs and represents an urgent incentive to invest “in new capabilities such as data analytics” EY 2016 medical technology report

2)   Shrinking revenues, pricing pressure from influential payers and hospital systems, in European socialized markets

This has forced medtechs to co-develop and partner with tech companies outside of their traditional boundaries to deliver shared-risk and value-based outcome to payers and patients. Omar Ishrak, CEO Medtronic, at JP Morgan Health Care Conference January 2016 already mentioned his “New Partnerships and Business Models based on Joint Accountability”. A few months later, Medtronic partnered with the digital brain of IBM Watson to improve diabetes treatments.

3)   Data as a common language

Christian Krey, CEO of Emperra, explains to us that “Medtech companies in our ecosystem have always been familiar with creating and using data for patients’ benefit. They understand the value of data and how to use and combine them to find new business models. Most Pharma companies still see their future in selling molecules, having a longer way to data-driven business models. For a digital health startup a partnership with a medtech company will leverage both partners.

patient centered care

4)   A “patient-centric offer” as the baseline

between medtechs and digital health startups, says Gabriel Enczmann, Director Business Development at mySugr. “They are both allowed to market and speak to patients directly while pharma is highly regulated on what can be said or not said about their product to patients “

5)   Moving “beyond the product“ into long-term Integrated health solutions.

Andreas Joehle, CEO & Chairman of the board of directors at Hartmann, stipulates clearly that his industry must re-think healthcare to create sustainable solutions: “we need to drop individual agendas and have an open-minded conversation about how to make real improvements. This needs to involve stakeholders from the entire healthcare value chain, as well as having people from outside the industry to bring new perspectives”. “Mobile apps have quickly established themselves on the healthcare scene and can help monitor everything from blood sugar levels to heart rates and cholesterol levels”

At Frontiers Health 2016, Dierk Beyer, Partner and co-founder of TransAct Advisory who see real-life digital health exit transactions confirms “If you combine a gadget with an IT platform, this can be interesting for both Medtech and startups. The links to disease monitoring represents a tremendous value to Medtech”

6)   The unique value of proximity and relationships built by startups with their end-users

Pritt Krus, CEO of Dermtest, from Estonia emphasizes how relationships catalyze sound  discussions: “As a digital health startup employing software and hardware solutions we have several potential cooperation points; yet quite often the extent and relevance of cooperation possibilities become clear only after a good relationship has been established with our main stakeholders first – doctors and patients – and there is initial traction with the service.”

This growing loyal community of doctors is what Touch Surgery, founded by CEO MD Jean Nehme, succeeded in building. Its cutting-edge surgery simulation app helps surgeons train ahead of complicated surgery procedures, or to familiarize themselves with new surgical procedures. Jean highlights that “The key to startup success is the ability to articulate the “new” and the “old” way in the startup “pain killer” value proposition to your Medtech partner. The winning agreement between both sides lies somewhere between the new disruptive way and the traditional model looking at long-term and existing practice”, which Touch Surgery did with J&J Ethicon, Stryker, Smith& Nephew and Zimmer to name just a few.

sm_digital-health_hilchshutterstock

7)   Medtechs and Digital Health Startups are ready from both an organizational and investment perspective to build strategic collaborations

Creating a global and local synergy in the partnerships

As Gabriel Enczemann from mySugr reveals, their successful startup approach has been on two levels as they are expanding from Austria, to the US, Germany, Italy, Belgium and Canada with the big Medtech Roche Diabetes. Speaking with champions and affiliates from two continents did help them build a global offering service that includes as well ready-to-pick options for country affiliates.

Synergy between startup R&D and medtech Regulatory know-how

“Partnering for a startup with a big medical device organization is like having an external regulatory department, and the startup is like the medical device organization’s innovation External lab” says Frederic Lordachs, co-founder and partner at Doctoralia from Spain.

One thing is sure: Roche’s acquisition of MySugr predicts further digital health acquisitions by Life Sciences companies, increased digital health valuations and investor interests. What digital health startups have recently built with Medtech companies will pay off in a shorter timeframe.

tram

About the author
Tram Trinh combines executive entrepreneurial and corporate health tech industry experience, as well as non-executive roles across Fortune 500, Privately-held Medium-Sized Business to Not-For-Profit organizations. She has lived and worked worldwide and founded VITANLINK to bring societal impact, co-founding and co-developing ventures in Medical Devices & Diagnostics | Telemedicine | Digital Health-eHealth | Artificial Intelligence

Picture sources
https://medtechboston.medstro.com/blog/2015/02/23/massachusetts-bets-on-digital-health https://www.healthcare-informatics.com/blogs/rajiv-leventhal/are-consumers-ready-patient-centric-healthcare
http://www.kpcb.com/blog/six-truths-digital-health-entrepreneurs-need-to-know

In the life of a person, for whom daily intake of various medications is a necessary evil, an easy-to-use and efficient reminder is a life-saviour. When it comes to meds, everything has to work precisely. I know how easy it is to forget to take a pill on time. I also understand that the price is high for forgetting to take the medicine. After all, you can never expect to reach the desired effect from pills if you don’t take them, right? The challenge of keeping track of the prescribed medications can be met with a smartphone in your hand and MyTherapy Med Reminder downloaded on it.

MyTherapy_Blutdruck

MyTherapy is a must-have application for every person who has to take medication regularly. This digital helper can take some weight off your shoulders by allowing you to set reminders for all kinds of medications, measurements and activities. I am going to present you a list of strong points of this application and explain why, in my opinion, it is one of the best reminder apps I have ever used.

  1. If you are looking for an application that can connect you with your doctor and do all the job of explaining him how successful you are in following the prescription, MyTherapy is a good tool for that. The application allows you to share reports with your physician. These reports are handy because they visualize the progress in your treatment which makes it easier for the doctor to detect any inconsistencies in your medication schedule. He can also decide if the dosage of your medication needs some correction, because all the measurements and symptoms can be entered and saved, making it easier for your doctor to understand the effect of the given medication portion.
  1. MyTherapy is an application that is incredibly easy and convenient to use. After registering and entering your personal data, you can create a list of all the medications you take throughout the day. If the medicament is not in the database, you can enter the data manually, thus saving all the necessary information about the medicament and creating a reminder. There is a long list of symptoms and activities that you can choose from when you are to report in detail how you feel and what you do during a day. You can also be reminded to describe how you feel after taking a medicament and save this information for later to review with your doctor. Another useful feature is the ability to set reminders for meds that demand a different schedule of intake – every hour, every day or every week. Afterwards, all you need to do is just cross them out as you complete the task, feeling satisfied and happy.

    Screenshot_4

  2. In many applications, the importance of communication between app developers and app users is neglected. However, the creators of MyTherapy seem to be willing to change that, communicating actively with the app users and trying to help in any way to work on the improvement of the app. They are working with us to deliver a product that meets our needs and ensures that all users are satisfied with the results. It is essential to be able to share your opinion and, in some cases, criticism with the people responsible for the usability and functionality of the app.

There was just one little drawback that I encountered while using the app. The list of medicaments that I could choose from was very short and I had to type all the information manually. Scanning the barcodes of the meds didn’t help, because all the medicines I take were not available in the database. It is just a minor flaw but it was a bit frustrating because the list of the pills I am taking is pretty impressive and not a single one could be scanned. Fortunately, this little thing doesn’t have a bad influence on the overall performance of the application, because once you are done with entering the data, you can relax while the app is working its magic.

Conclusion

All in all, I would say that this application is great. If you use it, you don’t have to be afraid to miss a single pill anymore. It takes all your medications and overall health data under control and helps you stay organized to help regulate potential health problems. The application does its job in simplifying complex medication schedules and taking your mind off from constant control over your health maintenance. This very sophisticated reminder has everything that a person with a chronic condition needs to maintain his health and lifestyle on the habitual level.

The application is free to download on the App Store or Google Play.

Evgeniya Jung, a digital nomad, studied at the department of International Relations in Russia. She moved to Switzerland two years ago and since then she has been travelling and working on improvement of her German skills. She has particular interest in digital healthcare due to having Type 1 Diabetes, which gained her vast experience with the health care systems in different countries.

Pictures: zVg by MyTherapy / http://www.smartpatient.eu/de/

Arbeitsrecht

Die Nutzung von Social Media Kanälen von Grossunternehmen über Behörden und Verwaltungen bis hin zu KMU’s in der Schweiz nimmt von Jahr zu Jahr zu. Die Nutzung von sozialen Netzwerken kann jedoch auch zu arbeitsrechtlichen Problemen führen. In der Donnerstagsrunde vom 4. Februar 2016 an der HWZ in Zürich gab der Vortrag von Frau lic iur. Gabriela Baumgartner, LL.M einen Einblick in diese arbeitsrechtlichen Aspekte. 

Gabriela Baumgartner arbeitet als Juristin und Journalistin beim Schweizer Radio und Fernsehen. Zudem ist sie Redaktorin der Sendungen “Kassensturz” und “Espresso” und Dozentin an der Hochschule für Wirtschaft in Zürich. Durch Fälle aus dem Alltag ist der Vortrag vom 4. Februar entstanden.

Da Social Media von immer mehr Unternehmen genutzt wird, stellen sich auch immer mehr arbeitsrechtliche Fragen. Ist die Nutzung von Facebook während der Arbeitszeit zulässig und in welchem Umfang? Welche Äusserungen auf sozialen Plattformen könnten heikel sein? Welche Rolle spielt dabei die Meinungsfreiheit? Einen weiteren wichtigen Punkt stellt das Veröffentlichen von Bildern dar. Wann berührt ein benutztes Bild ein Persönlichkeitsrecht und welche arbeitsrechtlichen Konsequenzen kann schliesslich die Nutzung von sozialen Netzwerken nach sich ziehen?

Die private Nutzung von sozialen Netzwerken während der Arbeitszeit ist grundsätzlich zulässig. Dies halten die EMRK (Europäische Menschenrechtskonvention) und verschiedene Bundesgerichtsentscheide fest. Dabei hat der Arbeitnehmer den Anspruch während der Arbeitszeit private Tätigkeiten erledigen zu dürfen. Dennoch wird dem Arbeitgeber eine Regelungskompetenz durch das Obligationenrecht zugewiesen. Dabei kann der Arbeitgeber dem Arbeitnehmer verschiedene Weisungen angeben, wie er sich am Arbeitsplatz zu verhalten hat. Diese Weisungen sind je nach Unternehmen verschieden und auch unterschiedlich streng angelegt. Es kann also festgehalten werden, dass eine private Nutzung von Facebook, Twitter & Co. zulässig ist, aber der Arbeitgeber sich an die Weisungen des Arbeitgebers halten muss.

Auf sozialen Netzwerken werden täglich Äusserungen gemacht. Dabei muss aus arbeitsrechtlicher Sicht berücksichtigt werden, dass gewisse Äusserungen nicht getätigt werden dürfen. Trotz der Meinungs- und Informationsfreiheit der Bundesverfassung darf man im Namen des Unternehmens nicht alles äussern. So können zum Beispiel rassistische Bemerkungen strafrechtlich verfolgt werden.

Die Kommunikation via Social Media funktioniert heute stark über Bilder. So veröffentlicht beispielsweise die Kantonspolizei Zürich Bilder von gesuchten Straftätern und bittet die Bevölkerung um Hilfe.

Auch im Gesundheitswesen werden soziale Netzwerke stark genutzt, um Interessierte mit laufend neuen Informationen zu versorgen und potenzielle Patienten von einem Konzept zu überzeugen. Auch Nutzen immer mehr Ärzte soziale Netzwerke, um sich mit anderen Ärzten austauschen zu können. Ein schönes Beispiel stellt der Twitter-Auftritt des Universitätsspitals Zürich dar. Jedes Unternehmen in der Gesundheitsbranche muss dabei darauf achten, was geäussert wird und welche Bilder hochgeladen werden.

Ein spannendes Beispiel eines Arztes hat zu einem interessanten Fall geführt. Der betreffende Arzt wollte sich mit anderen Ärzten auf Facebook bezüglich eines Röntgenbildes einer Patientin austauschen. Dafür lud er ein Röntgenbild der betreffenden Patientin auf Facebook hoch und vergass dabei, den Namen auf dem Röntgenbild zu löschen. Welche arbeitsrechtlichen Aspekte können hier nun aufgezeigt werden?

Zum einen hat der Arzt das Persönlichkeitsrecht der Patientin verletzt. Dies wird durch den Art. 28 im ZGB geregelt. Dabei muss die abgebildete Person der Veröffentlichung des Bildes zustimmen. Dies konnte die Patientin nicht. Zum anderen könnte diskutiert werden, ob der Arzt gewissen Weisungen des Arbeitsgebers nicht gerecht worden ist, indem er das Bild veröffentlicht hat und eine Treuepflichtverletzung vorliegt.

Das Nutzen von Social Media-Plattformen ist eine neue Art der Kommunikation und Meinungsäusserung mittels Text und Bild und stellt die Nutzer einerseits vor neue Möglichkeiten, aber auch vor neue Probleme. Nicht alle Äusserungen können problemlos getätigt werden und nicht jedes Bild sollte auf soziale Netzwerke hochgeladen werden. Um arbeitsrechtlichen Konsequenzen ausweichen zu können, sollten die neuen Medien mit Vorsicht genutzt werden. Für Arbeitgeber wird empfohlen, Reglemente zur Nutzung von elektronischen Medien und sozialen Netzwerden zu erlassen. Zudem kann eine Schulung der Mitarbeitenden in Bezug auf Social Media hilfreich sein.

Carmen Schneider studiert im Master an der Universität Luzern und arbeitet neu als Redaktorin bei Healthinar. Mit grossem Interesse am Gesundheitswesen möchte sie bei Healthinar ihr Wissen in Kommunikation und Marketing in einem neuen Bereich vertiefen.

Bildquelle: http://www.verkehrsrecht-gladbeck.de und http://www.jobnet.de

It’s been more than 25 years since communism became history in Romania. But the reality is that the country needed a lot of time to adjust to the new economy, especially after we became a EU member in 2007. Fortunately, there have been many positive developments lately, which also apply to our health care system.

Everybody in Romania knows that you should try to avoid any encounter with the public health care system. It’s true that we have good doctors, but many of them decide to leave the country and seek work abroad. That’s mainly because their educational background gives them the opportunity to find a job outside Romania which pays according to their responsibility. Plus, the Western European hospitals provide better medical equipment than we have here.

On the other hand, the private health care system has strongly improved and it is well established in all the big cities in our country. Most of the big companies provide their employees with private medical insurance, so they are not forced to go to public hospitals which are financed through taxes.

Comparing the two sectors – the public and the private one – I would base my opinion on my personal experience. Fortunately, I did not have to spend too much time in hospitals; But I happened to stay in a public hospital for one week, when I was younger, and then three years ago I experienced a regular check in a private clinic. With these two very different experiences in mind, I can try to provide a comparison: In 2004, when I was 13 years old, I had my appendix removed. I was obligated to go to the closest hospital to my home, which was in a small town, and I had to spend an entire week there. For the first three days, I had to share the room with the boys, because the girls’ room was already full. So this is the first bad experience with the public sector – it was too crowded.

Later, when one of the girls left the hospital, they moved me from the boys’ room. But guess what? They did not change the bed sheets. Luckily, there was a friend of mine and she told me about it. So my mother brought our own bed sheets from home. This example shows that hygiene was another problem.

In addition, the surgery was supposed to be free of charge, since I was under 18 years old, but nobody would have even looked at me, if my parents did not give them money.

Eight years later, I had a very different first experience with the private health care system in Bucharest. I wanted to do a regular check and decided to give the most modern clinic a try.. What I found really interesting and different about it was that after my website registration, somebody called me to confirm my appointment. After that, I received an email with the appointment and the name of the doctor who was going to see me. Of course I googled him and checked for reviews. Everything was fine so I felt confident about the appointment. One day before my appointment, I also received a text message as a reminder. The entire communication process was very professional and transparent.

When I got to the clinic, I was impressed by the look of the place, but even more important, everybody was nice and helpful. I was also very pleased by the service and by the medical equipment which seemed a latest generation one. And then it hit me: I am their customer and they treat me as such. It’s impossible to find such behaviour in a public hospital, when everybody acts like you completely depend on them and they do not need you at all.

I received the results of the check-up on the spot, and left being very impressed.And it got even better when I checked my messages: I had an email from them asking for feedback. So I said to myself that this was proper marketing and they really knew how to use it. I was surprised because that was the first time I noticed marketing being used in health care system. But it was this moment that I understood how a different approach makes a huge difference between the public and the private health care system.

Because of these different approaches and the great difference regarding the quality of the services, I believe the entire health care system in Romania will be dominated by the private sector in the near future. This is already happening with dental practices and everybody is leased with it. If public sector does not reform quickly, there won’t be any doctors left bofore long – and no patients either.

Ioana Vasiloiu has a Master’s degree in International Relations gained in Bucharest – Romania, and also studied International Marketing in Poland. She has been working as a Social Media Coordinator for two years now and is enthusiastic about new developments in marketing.

On June 11 2015, our event at the EB Zurich was a huge success, thanks to our fantastic four speakers, all coming from renowed hospitals in Zurich. There was:

– Andrea Heiniger, Social Media Manager, University Hospital Zurich.

– Stefan Lienhard, Project Leader Social Media, Hirslanden Private Hospital Group

– Renate Good, Head of Corporate Communications, Hospital Bülach

– Patrick Jola, Communications Officer & Assistant to CEO, Forel Clinic

After some opening words by our CEO & CMO, the four speakers presented their institutions social media strategies in a short presentation. After that, the public had the chance to discuss the topic in an inspired atmosphere with lots of questions and a refreshing networking reception afterwards.

Thank you all for making this first event unforgettable!

Take a look at HEALTHINAR’s trip to Barcelona and taking part in the Health 2.0 conference in Barcelona: Watch the story here.

The Health 2.0 conferences really are the place to be if you are interested in patient-provider communication, consumer health, data analytics and healthcare tech. All this was shown in exciting panels and more than 50 demos. Some interesting examples were:

– iRCP: http://bit.ly/1dh3GZw

– Hospital Simulation by Attensi: http://www.attensi.com/

– Simplifying diagnostics my MESI: http://www.mesimedical.com/homepage/

– Sense.ly with their virtual nurse Molly: http://sense.ly/

– The mobile wound management tool Wounddesk: http://wounddesk.com/

And of course we were also very impressed by the Jessica Feder, Chief Digital Officer at Bayer and the Grants4Apps Accelerator-Programme, check it our here: https://www.grants4apps.com/accelerator/

However, they were many more impressive demos and panels, we would like to thank them and of course to the awesome organisation of Health 2.0. See you all next year the latest!

Last but of course not least, we are proud to present to you our 4th speaker at the next HEALTHINAR-event: Renate Good, Head of Corporate Communications, at Hospital Bülach, near Zurich in Switzerland.
A few years ago, Renate wrote a paper about social media and hospitals, titled “Wie viel Social Media braucht ein Spital? Quantifizierung der Social Media-Nutzung Amerikanischer, Deutscher und Schweizer Spitäler“, where she took a look at the social media use of diverse American, German and Swiss hospitals. Her conclusion, back then in 2011, was that it was unclear if and how much social media a hospital was needed. There were very few examples of institutions that used this new communication channels. However, Renates Goods prediction was that with an increasing competition and therefore more competitive pressure between hospitals, the need for more customer or patient loyalty would also rise. In terms of that social media would be taken into further consideration for a communication strategy in hospitals. If we look at the situation today this has mostly become true. With SwissDRG (Swiss fee-per-case system) there’s more competition, especially between private and public hospitals in Switzerland and also quite a few institutions are using various social media channels.
So it’s most interesting that the Hospital Bülach, where Renate Good works, is still not present on these channels. We are looking forward to Renates presentation and a lively discussion, thanks for participating!

More about the Hospital Bülach: http://www.spitalbuelach.ch

More about Renate Good:  http://www.spitalbuelach.ch/index.php?id=1652

We are proud to announce that the Social Media Manager from the UniversityHospital Zurich in Switzerland will be one of the four speakers at our first showcase about hospitals and social media. The hospital exists since 1204 and is today one of the largest hospitals in the country including exceptional academic research. It consists of 43 departments and institutes and provides medical support to 39’000 inpatients every year.
Their social media campaign has been long awaited and was finally released in April 2015. So we are very excited to see their extensive campaign expanding and have Andrea Heiniger speaking on behalf of the USZ as a social media newcomer at our event.Thank you!

andrea_heiniger

More about the UniversityHospital Zurich:
USZ
More about the social media campaign of the USZ:
http://blog.usz.ch/willkommen-in-den-social-media/Blog
Twitter: Twitter
For more information on HEALTHINAR follow this blog or visit us on
Twitter: https://twitter.com/healthinar